A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Jiangping Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui Provincial Engineering Laboratory for Screening and Re-eva…. Hauptthemen laut MEDLINE: Pueraria, Gastrointestinal Microbiome, Polysaccharides, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui University of Chinese Medicine, Studio.
Abstract (Originalsprache)
BACKGROUND: Hepatic fibrosis, driven by oxidative stress and subsequent hepatocellular injury, represents a major worldwide health challenge. Pueraria lobata Radix, a traditional Chinese herb, contains polysaccharides with demonstrated hepatoprotective properties, though their mechanisms remain incompletely defined. PURPOSE: This study aims to characterize the structure of P. lobata polysaccharide (PLP2) and to decipher its protective mechanisms against hepatic fibrosis. METHODS: PLP2, a homogeneous, water-soluble polysaccharide, was purified from P. lobata and structurally characterized. Subsequently, the hepatoprotective activity of PLP2 was investigated in a CCl₄-induced murine model of hepatic fibrosis. RESULTS: Structural analysis indicated that PLP2 (Mw = 142.9 kDa) was mainly composed of (1→4)-α-D-Glc and (1→4)-α-D-GalA units, with a minor presence of →4,6)-α-D-Glc-(1→ residues. In a CCl₄-induced murine model of hepatic fibrosis, PLP2 treatment effectively ameliorated liver injury, histopathological damage, and inflammatory responses. Mechanistically, PLP2 treatment restored mitochondrial ultrastructure and hepatic ATP levels, thereby suppressing hepatic ferroptosis through the activation of the Nrf2/HO-1/GPX4 axis. The indispensable role of Nrf2 was further validated using the inhibitor ML385, which abolished PLP2's protection. Notably, the hepatoprotective effects of PLP2 were predominantly dependent on gut microbiota integrity, as direct PLP2 treatment failed to protect hepatocytes in vitro. This role was further confirmed by the abolition of protection with antibiotic treatment and the transfer of benefits via fecal microbiota transplantation. CONCLUSION: These findings provide evidence that PLP2 exerts its anti-fibrotic effects through the gut microbiota-dependent suppression of ferroptosis via the Nrf2/HO-1/GPX4 axis, providing a solid scientific foundation for the clinical application of P. lobata.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui Provincial Engineering Laboratory for Screening and Re-evaluation of Active Compounds of Herbal Medicines in Southern Anhui, Anh…
Förderung
- National Natural Science Foundation of China
- Anhui University of Chinese Medicine
- Studio
- Anhui Provincial Department of Education
- Natural Science Foundation of Anhui Province
Zitieren
APA
Wu, J., Yang, Z., Chen, L., Xu, Q., Zhang, Y., Yang, Y., Beloved, M., Zhan, S., Cao, W., Li, Z., Wang, G., Lv, Q., & Han, J. (2026). A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158123
Vancouver
Wu J, Yang Z, Chen L, Xu Q, Zhang Y, Yang Y, et al. A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158123
BibTeX
@article{Wu2026,
author = {Wu, Jiangping and Yang, Zhu and Chen, Lingzhi and Xu, Qiangbao and Zhang, Yingying and Yang, Yiping and Beloved, Mabhena and Zhan, Sumiao and Cao, Wen and Li, Zihan and Wang, Guodong and Lv, Qiuyue and Han, Jun},
title = {A polysaccharide from Pueraria lobata ameliorates hepatic fibrosis via gut microbiota-dependent suppression of ferroptosis},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158123}
}
EUVIMED